Investors with a short-term perspective can consider buying the stock of Suven Life Sciences at current levels of ₹244.8.

The stock gained 4.7 per cent accompanied by above average volume on Monday, breaching a key resistance at ₹235 as well as the 21-day moving average.

There has been an increase in daily volume over the last three trading session. The near-term outlook is bullish for the stock. It has the potential to trend upwards and reach the price targets of ₹255 and ₹260 levels in the ensuing trading sessions. Traders with a short-term view can buy the stock with a stop-loss at ₹239.